Stock Pulse
Philip Morris International (PM) exceeded Q4 2024 earnings expectations with 14% EPS growth and 7% sales growth, driven by strong demand and innovation in smoke-free products like Zyn and IQOS [2], [4]. Smoke-free products now represent a substantial portion of PM's revenue and gross profit, exceeding 40 billion units sold [2], [5]. The company maintains a strong dividend yield of 3.5% and Dividend King status [2], [4]. While some articles suggest alternative investments like AI stocks [3], [5], [6], PM's positive FY25 outlook with projected 8.9% year-over-year earnings growth and continued focus on smoke-free products strengthens its market position [2], [4]. Several insider stock sales occurred due to tax obligations related to vested stock units [11], [12], [13], [14], [15].